Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fridkin

Showing results (111-120 of 254) with videos related to

Pageof 26
Sort By:
Immunopharmacology|August 1, 1997
Tuftsin-THF-gamma 2 chimeric peptides: potential novel immunomodulatorsR Granoth, E Vadai, Y Burstein, et al.
Journal of Inorganic Biochemistry|July 8, 2000
Insulin-like effects of vanadium: basic and clinical implicationsI Goldwaser, D Gefel, E Gershonov, et al.
Biochemical and Biophysical Research Communications|July 28, 1978
Specific binding sites for the phagocytosis stimulating peptide tuftsin on human polymorphonuclear leukocytes and monocytesY Stabinsky, P Gottlieb, V Zakuth, et al.
Journal of Medicinal Chemistry|November 22, 1996
1-Aminocyclobutanecarboxylic acid derivatives as novel structural elements in bioactive peptides: application to tuftsin analogsE Gershonov, R Granoth, E Tzehoval, et al.
Endocrinology|May 1, 1994
Stearyl-norleucine-vasoactive intestinal peptide (VIP): a novel VIP analog for noninvasive impotence treatmentI Gozes, A Reshef, D Salah, et al.
Journal of Biological Response Modifiers|December 1, 1988
Antigen-tuftsin conjugate signals interleukin-1 synthesis and secretionS Dagan, E Tzehoval, B Tartakovsky, et al.
FEBS Letters|September 12, 1988
C-reactive protein decreases protein phosphorylation in stimulated human neutrophilsR Buchta, R Gennaro, M Pontet, et al.
Biochemical and Biophysical Research Communications|November 27, 1985
High levels of vasoactive intestinal peptide in human milkH Werner, Y Koch, M Fridkin, et al.
European Journal of Pediatrics|April 1, 1988
Growth hormone releasing factor and somatostatin concentrations in the milk of lactating womenH Werner, P Katz, M Fridkin, et al.
Archives of Disease in Childhood|July 1, 1980
Decreased serum tuftsin concentrations in sickle cell diseaseZ Spirer, Y Weisman, V Zakuth, et al.
Pageof 26

Showing results (111-120 of 254) with videos related to

Sort By:
Pageof 26
Immunopharmacology|August 1, 1997
Tuftsin-THF-gamma 2 chimeric peptides: potential novel immunomodulatorsR Granoth, E Vadai, Y Burstein, et al.
Journal of Inorganic Biochemistry|July 8, 2000
Insulin-like effects of vanadium: basic and clinical implicationsI Goldwaser, D Gefel, E Gershonov, et al.
Biochemical and Biophysical Research Communications|July 28, 1978
Specific binding sites for the phagocytosis stimulating peptide tuftsin on human polymorphonuclear leukocytes and monocytesY Stabinsky, P Gottlieb, V Zakuth, et al.
Journal of Medicinal Chemistry|November 22, 1996
1-Aminocyclobutanecarboxylic acid derivatives as novel structural elements in bioactive peptides: application to tuftsin analogsE Gershonov, R Granoth, E Tzehoval, et al.
Endocrinology|May 1, 1994
Stearyl-norleucine-vasoactive intestinal peptide (VIP): a novel VIP analog for noninvasive impotence treatmentI Gozes, A Reshef, D Salah, et al.
Journal of Biological Response Modifiers|December 1, 1988
Antigen-tuftsin conjugate signals interleukin-1 synthesis and secretionS Dagan, E Tzehoval, B Tartakovsky, et al.
FEBS Letters|September 12, 1988
C-reactive protein decreases protein phosphorylation in stimulated human neutrophilsR Buchta, R Gennaro, M Pontet, et al.
Biochemical and Biophysical Research Communications|November 27, 1985
High levels of vasoactive intestinal peptide in human milkH Werner, Y Koch, M Fridkin, et al.
European Journal of Pediatrics|April 1, 1988
Growth hormone releasing factor and somatostatin concentrations in the milk of lactating womenH Werner, P Katz, M Fridkin, et al.
Archives of Disease in Childhood|July 1, 1980
Decreased serum tuftsin concentrations in sickle cell diseaseZ Spirer, Y Weisman, V Zakuth, et al.
Pageof 26